UK Space Biomed Consortium

为英国利益制定的英国空间生物医学战略英国空间生物医学联盟由来自英国各地的一些学术组织和工业公司的27个机构组成。该联盟正在确定、提议、批准并随后推行一项战略，其核心是加强学术和工业组织之间的交流、协调和合作，并在适当情况下与政府组织合作。该战略的目的是在英国正式建立和发展空间生物医学领域。它将集中联合王国空间生物医学联盟成员（以及任何未来成员）的资源，以实现以下目标。AIMSi。受益于地面医疗保健。2。加强英国创新和经济增长。3。为英国有效参与未来人类航天活动做好准备。iv.为英国sbc会员的利益服务。促进国际合作，并从中受益。远景联合王国空间生物医学联盟的成员将着手采取行动，使联合王国正式承认空间生物医学领域。由该联盟协调并在全国开展的空间生物医学活动将减少人口老龄化的负面影响，改善地面保健服务，并使该国为即将到来的新空间时代（以商业载人航天为基础的时代）做好准备。英国空间生物医学联盟计划将自己建立为一个由学术界和工业界成员组成的研究所，他们将根据以下主题制定4个研发和商业产品计划；老龄化、生活方式与营养远程医疗/电子保健/生物技术与太空旅行有关的发病率。4. 人为因素与绩效。

A UK Space Biomedicine Strategy for the Benefit of the UKThe UK Space Biomedicine Consortium consists of 27 establishments from a number of academic organisations and industrial companies from across the UK. The Consortium is in the process of identifying, and will propose, ratify and subsequently pursue a strategy centred upon augmented communication, coordination and collaboration between academic and industrial, and where appropriate, Governmental, organisations. The strategy aims to formally establish and develop space biomedicine as a field within the UK. It will focus the resources of the UK Space Biomedicine Consortium members (and any future members) to enable the following aims to be achieved. AIMSi. Benefit terrestrial healthcare. ii. Enhance UK innovation and economic growth. iii. Prepare the UK to effectively participate in future human spaceflight activities. iv. Benefit / serve the interests of UKSBC members.v. Contribute to, and benefit from, international collaboration.Vision The members of the UK Space Biomedicine Consortium will embark upon a course of action that shall result in the official recognition of the domain of space biomedicine within the UK. The space biomedicine activities coordinated by the Consortium and undertaken across the nation will diminish the negative impact of an ageing population, improve terrestrial healthcare provision and prepare the country for the new space era that approaches (one based upon commercial human spaceflight). The UK Space Biomedicine Consortium intends to establish itself as an Institute with members drawn from academia and industry, who shall develop 4 R&D and commercial product programmes according to the following themes;1. Ageing, Lifestyle & Nutrition2. Telemedicine / e-Health / Biotechnology 3. Morbidity in relation to space travel. 4. Human Factors and Performance.